Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ionic liquid microwave method for metoclopramide hydrochloride production ensuring high purity and cost efficiency for pharmaceutical supply chains.
Patent CN112250639B details a novel Ru/Cu-catalyzed route for heterocyclic arylamines. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN110066244B reveals a high-yield method for chiral tetrahydroquinoline synthesis using saturated aldehydes, offering >99% ee and significant cost reduction potential.
Patent CN110590823A reveals non-transition metal catalysis for borate derivatives. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN113039175A reveals a scalable catalytic route for arylsulfonyl acrylonitriles, offering cost-effective and environmentally benign manufacturing solutions for global supply chains.
Novel patent CN106478525A details an iridium-catalyzed tandem synthesis of quinazolones using oximes, offering high atom economy and simplified purification for pharmaceutical intermediates.
Patent CN111217844B details a cost-effective 1,1-diboronation of olefins using Cp2ZrCl2. This method offers high atom economy and scalability for reliable pharmaceutical intermediate supply chains.
Patent CN111690009A discloses novel Co/Fe complexes for high-ee hydrogenation of alpha-silyl styrenes, offering cost-effective pharma intermediate synthesis.
Patent CN104402943A reveals a novel Pd-Cu heteronuclear catalyst for efficient quinoline derivative synthesis, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN107739322B details a novel Ir-catalyzed C-H activation route for sulfonamides. Discover cost-effective, high-yield manufacturing solutions for pharma and agrochemical intermediates.
Patent CN107759510B enables metal-free synthesis. Delivers high-purity intermediates with reduced costs and scalable supply chain reliability for global buyers.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN110372613B reveals a metal-free route to 2,3,6-trisubstituted pyrazine N-oxides. Mild conditions ensure high purity and cost-effective manufacturing for global supply chains.
Patent CN103193830A reveals a flexible route for chiral ferrocene phosphine ligands, offering cost reduction in pharmaceutical intermediate manufacturing and reliable supply.
Efficient ruthenium-catalyzed method reduces costs and environmental load for high-purity pharmaceutical intermediates manufacturing supply chain.
Patent CN103435635B reveals improved TMPMgClLiCl synthesis. Enhances yield and supply chain stability for pharmaceutical intermediate manufacturing globally.
Novel ruthenium catalyst enables low-loading synthesis of quinoline derivatives reducing costs and improving supply chain reliability for pharmaceutical intermediates.
Patent CN118027091A reveals efficient treprostinil route. Offers supply chain reliability and cost reduction in API manufacturing for global partners.
Patent CN111732612A reveals a stable iron-carborane catalyst for synthesizing trans-2-alkenylazaarenes, offering cost reduction in API manufacturing and mild reaction conditions.
Novel C-H activation method for spiro quinazolinones offers high yield and scalability for reliable pharmaceutical intermediate supply chains.